Market revenue in 2024 | USD 313.1 million |
Market revenue in 2030 | USD 473.2 million |
Growth rate | 7.1% (CAGR from 2024 to 2030) |
Largest segment | Cardiac resynchronization therapy (crt) |
Fastest growing segment | Defibrillators |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Cardiac resynchronization therapy (crt) was the largest segment with a revenue share of 43.24% in 2024. Horizon Databook has segmented the Mexico cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
The cardiac rhythm management devices market in Mexico is expected to grow significantly due to the increasing prevalence of cardiovascular diseases, coupled with government initiatives to provide better healthcare facilities. The market is also expected to be driven by the growing adoption of advanced technologies such as ICDs, pacemakers, and CRT devices.
However, penetration of medical devices in Mexico is low due to the language barrier and low investment in healthcare. Mexico’s healthcare system is dominated by private players, and healthcare delivery through private entities operates entirely as a free market.
For new entrants in the Mexican market, the Ministry of Health provides limited information about medical devices and IVDs in English. All the documentation must also be prepared in Spanish. According to a study by the National Institute of Statistics and Geography, SCA is the leading cause of death in Mexico in people above 65 years.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into Mexico cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account